OpenEvidence Funding: $700M Raised, Series D (2026)
OpenEvidence is a Healthtech company based in Miami, Florida. It has raised $700M in total funding. Latest round: Series D.
OpenEvidence funding overview
OpenEvidence is a Healthtech company based in Miami, Florida. OpenEvidence has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in January 2026. The round record for OpenEvidence runs through 2026; nothing later has been disclosed. Investors on record include Thrive Capital, DST Global, GV (Google Ventures), Kleiner Perkins, Sequoia Capital, Coatue and 5 others. 11 distinct backers are named across the disclosed rounds.
OpenEvidence has raised $700M in total disclosed funding across the rounds on record.
Who has invested in OpenEvidence?
Thrive Capital, DST Global, GV (Google Ventures), Kleiner Perkins, Sequoia Capital, Coatue are named among the investors backing OpenEvidence.
What was the latest OpenEvidence funding round?
The most recent disclosed round is a Series D, announced in January 2026.
Where is OpenEvidence based?
OpenEvidence is based in Miami, Florida.
What sector does OpenEvidence operate in?
OpenEvidence is tracked under Healthtech from Miami, Florida, with $700M in disclosed funding.
When did OpenEvidence last raise?
The last disclosed OpenEvidence round closed in January 2026 at Series D.
We update the OpenEvidence record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in Miami and their backers are listed below.
